KKR (KKR) is in exclusive talks with Germany’s Fresenius (FSNUY) to buy Eugin in a deal that would value the fertility clinics in Spain and Portugal at around $528.55M, Reuters’ reports, citing a report in the Spanish newspaper Cinco Dias. According to unidentified financial sources, KKR would buy the clinics with a Spanish partner.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on KKR:
- KKR sells over $560M of industrial real estate
- Apple asks Supreme Court to reconsider prior ruling in Epic dispute, TC says
- Epic Games lays off about 16% of workforce, Bloomberg reports
- The SEC’s Crackdown on Wall Street’s Use of WhatsApp Continues
- Epic asks Supreme Court to review Apple App Store ruling, Bloomberg says
